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Factors associated with measles 
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Ndemazie Nkafu Bechem6
There have been growing concerns of a potential re‑establishment of measles transmission in the 
United States (US) in the years to come. This study aims to explore potential factors underlying the 
resurgence of measles in the US by objectively assessing the associations between annual incidence 
rates (AIR), case importation, vaccination status and disease outbreaks. Data on measles transmission 
between January 1st, 2001 and December 31st, 2019 were obtained from the national centres for 
disease control and prevention (CDC) surveillance databases and other published reports. Changes 
in incidence rates over time were assessed by binomial regression models. Of the 3874 cases of 
measles in the US over the study period, 3506 (90.5%, 95% CI: 89.5–91.4) occurred in US residents. 
The AIR per million population in US residents over this period was 0.60 (95% CI: 0.59–0.61), with an 
overall significant increase over time (p = 0.011). The median percentage of imported and vaccinated 
cases were 36% [17.9–46.6] and 15% [12.1–23.2] respectively. There was a significant decrease in 
the percentage of imported cases (p < 0.001) but not of vaccinated cases (p = 0.159) over time. There 
was a moderate and weak negative correlation between the AIR and the percentage of imported and 
vaccinated cases respectively (r = –0.59 and r = –0.27 respectively). On multiple linear regression there 
was a significant linear association between the AIR and the number of outbreaks (p = 0.003) but not 
with the percentage of imported cases (p = 0.436) and vaccinated cases (p = 0.692),  R2 = 0.73. Strong 
negative and positive correlations were seen between the number of outbreaks and the percentage 
of imported cases (r = –0.61) and the of number states affected (r = 0.88) respectively. Despite the 
overall reduction in the percentage of imported cases of measles over the past two decades, pockets 
of internal transmission of the disease following importation via increasing number of outbreaks in 
unvaccinated subpopulations, reinforced by vaccine hesitancy, account for the sustained increase in 
measles incidence rates in the US. Controlling indigenous transmission through efficient vaccination 
coverage in at‑risk subpopulations and among international US travellers, improved disease 
surveillance and rapid outbreak containment are essential in curbing the measles resurgence.
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Even though measles had spread across North Africa and Europe in the sixteenth century, it was only imported 
to the Americas by European explorers in the  1650s1,2. Measles, however, became a notifiable disease in the 
United States (US) in 1912, with an estimated 6000 measles-related deaths on average annually in the first dec-
ade of  reporting3. With the introduction of the measles vaccine in 1963, measles remained under control in the 
US up until the late 1980s and early 1990s when new outbreaks were reported. These new outbreaks are known 
to have been due to the low vaccine coverage in the affected cities and the densely populated urban areas, with 
Hispanics and Blacks as the mainly affected  ethnicities4,5. Furthermore, the growing number of young mothers 
meant they mainly obtained immunity from vaccination rather than infection and so had lower antibody titres 
and antibodies to transfer trans-placentally to their children, who consequently had weaker immunities to 
resist  measles6. Likewise, health care providers failed to administer the vaccine to eligible  children7. However, 
the occurrence of measles in more than half of the vaccinated children aged 5–19 years of age, raised the suspi-
cion of a possible vaccine  failure8. After 1993, there was a significant drop in the number of measles cases and 
a noticeable change in the demographics of the affected population, switching from middle high-school and 
college students prior to then, towards adults due to the policy in place by all states that required school-aged 
children to receive 2 doses of the measles  vaccine6. The downward trend continued all through the 1990s and 
in 2000, by way of a highly effective vaccination program, measles elimination was declared in the  US6,9. The 
measles post-elimination era in the US had been relatively stable with low pockets of transmission and fairly 
stable incidence rates in the  country10. However, In recent years there has been a resurgence of measles in the US 
with the annual median number of cases and outbreaks between 2009 and 2014 standing at more than double 
the numbers in the first decade following  elimination11. These have resulted in growing concerns of a potential 
re-establishment of transmission of measles, and loss of the ‘measles elimination’ status by the US in the years 
to come if no appropriate health policy actions are  taken12. There are suggestions this resurgence of measles 
could be due to the declining vaccine coverage as a result of vaccine  hesitancy13 and an ever growing number of 
anti-vaccination movements as observed in some parts of the  country14. Given the highly infectious nature of 
 measles15, several factors could potentially favour the transmission of measles and consequent resurgence such 
as; population density; inter/intra-age contact; timing of the vaccination and waxing conferred immunity. This 
resurgence is likely multifactorial in origin, however, the contribution of various factors to this resurgence has 
not be ascertained and/or quantified. This study aimed to provide answers regarding possible reasons for the 
resurgence of measles in the US in recent years and propose solutions to help with its control by reviewing the 
epidemiology of measles transmission in the US over the past 19 years and exploring factors associated with this 
transmission. More specifically, this study had as objectives:
1. To describe the measles epidemiology in the US post-elimination (2001 to 2019).
2. To assess the association and correlation between the vaccination status, case importation, disease outbreaks 
and measles incidence rates over this period
3. To discuss potential reasons for the resurgence of measles in recent years in the US and propose potential 
solutions to the current measles crises.
Methods
Study design and data sources. This was an ecological study with trend analysis of all cases and out-
breaks of measles in the US over the past two decades. The epidemiology of measles and the respective out-
breaks between January 1st, 2001 and December 31st, 2019 were studied. This time period is often referred 
to as the post-elimination era. Data on measles were obtained from the National Centres for Disease Control 
and Prevention (CDC) surveillance databases including the National Notifiable Diseases Surveillance System 
(NNDSS)16, the Notifiable Infectious Disease and Conditions data, the Nationally Notifiable Infectious Diseases 
and Conditions, United States: Annual  Tables17, the measles-related morbidity and mortality weekly reports 
(MMWR)18 and other published reports. Standard surveillance case definitions for measles used by the respec-
tive state health departments for reporting measles cases over the years were according to the respective CDC 
measles case  definitions16.
Data management and analysis. Data extracted from the data sources, when provided, included: the 
overall number of measles cases per year, the number of imported cases, the number of cases in US residents, 
the overall number and proportion of vaccinated and unvaccinated cases, the number and proportion of vac-
cinated and unvaccinated US resident cases, the number of outbreaks, the number of states affected, the number 
of deaths, the main countries of importation and the most frequent virus strains per outbreaks. The total and 
US residents annual incidence rates (AIR) per million were computed as; the overall number of measles cases 
and the number of measles cases in US residents for that year respectively, divided by the crude estimates of the 
USA population at risk for that year as per the US census bureau  data19. Percentages of imported and vaccinated 
cases were calculated as; the number of imported and vaccinated cases respectively divided by the total measles 
cases and US resident cases respectively. Cases were considered as vaccinated if they had received at least a dose 
of the measles vaccine, while unvaccinated cases were considered as those who reported not having received 
the vaccine and those whose vaccination status were unknown. All statistical analyses were done using STATA 
14 statistical software. Categorical variables were reported as frequencies and percentages, continuous variables 
were reported as means with standard deviations and medians with interquartile ranges as appropriate. Graphs 
were plotted for annual incidence rates, vaccinated US resident cases and percentages, imported cases and per-
centages over time. Binomial regression models were used to assess for changes in annual incidence rates and 
percentage of imported and vaccinated cases over time. Pearson’s correlation coefficient was used to assess for 
the linearity between continuous variables. Linear regression models were built to assess for linear associations 
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between importation percentages, vaccination percentages, outbreaks and the AIR and corresponding regres-
sion equations were derived and reported. Multiple regression was used to assess for these linear associations 
while controlling for potential confounders. A complete case analysis approach was used to manage missing 
data as the complete cases were a random sample of the overall data. Statistical significance was considered for 
p values < 0.05.
Ethical considerations and reporting. This was an analysis of publicly available disease surveillance 
data and ethical approval was therefore not required. The ‘Strengthening the Reporting of Observational studies 
in Epidemiology’ (STROBE) guidelines were used for the reporting of this study (Additional file 1).
Results
General characteristics. Between 2001 and 2019, there was a total of 3874 cases of measles in the USA, 
3506 (90.5%, 95%  CI: 89.5–91.4) of whom were US residents, giving a median of 85 [55–188] total and 65 
[42–178] US resident cases of measles per year. A total of 160 outbreaks were reported over this period with 
a yearly median of 6 outbreaks and 18 states affected by the disease (Table 1). A median of 36% [17.9–46.6] of 
cases per year were due to international importation and a median of 15.1% [12.1–23.2] of US cases occurred in 
vaccinated people (Table 1). Up to a median of 66.7% of vaccine-eligible cases declined to be vaccinated due to 
religious beliefs (Table 1). A total of 8 deaths were reported over this period. A summary of the clinical charac-
teristics of the measles cases for each year is presented in Table 2. 
Trends in the measles annual incidence rates, imported cases and vaccination status. The over-
all measles incidence over this 19-year period was 0.66 (95% CI: 0.65–0.67) per million population and 0.60 (95% 
CI: 0.59–0.61) per million population in US residents. The annual number of measles cases in US residents ranged 
from 24 to 1211 cases, and the AIR per million in US residents ranged from 0.08 (95% CI: 0.05–0.11) to 3.68 (95% 
CI: 3.48–3.89). There was an overall increase in the AIR in US residents over time from 0.28 (95%CI: 0.23—0.34) 
in 2001 to 3.68 (95% CI: 3.48—3.89) in 2019, p = 0.011. The percentage of cases imported ranged from 6.3% to 
73% and an overall decrease in the percentage of imported cases over time was observed from 46.6% in 2001 to 
6.3% in 2019, p < 0.001. The percentage of vaccinated US residents ranged from 5.5% to 29.6% and decreased over 
time though not significantly from 29.6% in 2001 to 14.8% in 2019 (p < 0.159). Trends in the total and US residents 
AIRs, percentage of imported and vaccinated cases over time are presented in Figs. 1 and 2.
Table 1.  Clinical characteristics of measles cases between 2001 and 2019.
Characteristics, n = 19 Numbers
Overall cases
 Total 3874
 Median/year [IQR] 86 [55–188]
US resident cases
 Total 3506
 Median/year [IQR] 65 [42–178]
Imported cases
 Total 734
 Median/year [IQR] 27 [21–54]
Imported cases percentage (%)
 Median/year [IQR] 36 [17.9–46.6]
US residents vaccinated cases, n = 16
 Median/year [IQR] 10 [7–27] 
US residents vaccinated percentage (%), n = 16








Percentage of vaccine refusal due to religious beliefs (%), n = 6
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Association between measles annual incidence rates, imported cases, case vaccination status 
and outbreaks. Table 3 summarises the respective linear regression coefficients, intercepts, p values and  R2 
values for the linear associations between the percentage of imported cases, vaccinated cases, outbreaks and the 
AIR in US residents.
There was a moderate negative correlation and linear association between the percentage of imported cases 
of measles and the AIR in US residents (r = -0.59 and p = 0.008 respectively) (Fig. 3a and Table 3).
Regression equation: AIR = 1.503–0.027 * percentage of imported cases.
There was a weak negative correlation but no linear association between the percentage of vaccinated cases 
and the AIR in US residents (r = -0.27 and p = 0.308) (Fig. 3b and Table 3).
Regression equation: AIR = 1.191–0.036 * percentage of vaccinated cases.
There was a strong negative correlation and linear association between the percentage of imported cases and 
the number of outbreaks (r = -0.61 and p = 0.006 respectively) (Fig. 3c and Table 3).
Regression equation: Outbreaks = 15.579–0.205 * percentage of imported cases.
On the other hand, there was a weak positive correlation and no significant linear association between the 
percentage of unvaccinated cases and the number of outbreaks (r = 0.35 and p = 0.249 respectively) (Fig. 3d and 
Table 3).
Regression equation: Outbreaks = -19.182 + 0.329 * Percentage of unvaccinated cases.
There were significant increases in the number of outbreaks (p = 0.002) and states affected (p = 0.002) between 
2001 and 2019 (Fig. 4a). There was a strong positive correlation and linear association between the number of 
outbreaks and the number of states affected by measles (r = 0.88 and p < 0.001 respectively) (Fig. 4b and Table 3).
Regression equation: States affected = 13.593 + 0.742 * outbreaks.
On multiple regression, there was a significant linear association between the AIR in US residents and the 
number of outbreaks (p = 0.003) and no more with the percentage of imported cases (p = 0.436) after adjusting 
for number of outbreaks and vaccination status.
Multiple regression equation: AIR = -0.123–0.008 * percentage of imported cases + 0.009 * percentage of vac-
cinated cases + 0.106 * outbreaks.  (R2 = 0.73, p = 0.436, p = 0.692, and p = 0.003 respectively).
Discussion
This study sought to review the epidemiology of measles in the US over the past two decades and assess for 
potential associations between the percentage of imported cases, vaccinated cases, outbreaks and the annual 
incidence rates. There has been an overall significant increase in the incidence rate of measles in US residents, the 
number of outbreaks and states affected, and a decrease in the percentage of imported cases, over time. Despite 
this increase in measles incidence in the US over time, in absolutely terms this incidence rate remains low, and 
relatively small when compared to the incidence of measles  worldwide20.
It is believed that since the elimination of measles in the USA, most measles cases and transmission in the US 
have been from importation due to international  travel21. The large outbreaks in several countries in Europe in 
recent  years20 have significantly reinforced the disease burden due to importation by non-vaccinated international 
Table 2.  Annual measles incidence rates, percentage of imported and vaccinated cases per year in the United 









cases (%) Out- breaks States affected Deaths
2001 116 81 0.28 (0.23–0.34) 54 (46.6) 24 (29.6) 10 22 0
2002 44 36 0.13 (0.09–0.16) 18 (40.9 5 (13.9) 3 17 0
2003 56 38 0.13 (0.09–017) 24 (42.9) 9 (23.7) 3 15 2
2004 37 24 0.08 (0.05–0.11) 27 (73.0) 4 (16.7) 2 13 0
2005 66 59 0.20 (0.15–0.25) 24 (36.4) 7 (11.9) 3 16 0
2006 55 42 0.14 (0.10–0.18) 31 (56.4) 11 (26.2) 4 16 0
2007 43 31 0.10 (0.07–0.14) 29 (67.4) 7 (22.6) 4 15 0
2008 140 127 0.42 (0.36–0.47) 25 (17.9) 7 (5.5) 9 15 0
2009 72 65 0.21 (0.17–0.26) 21 (29.2) 8 (12.3) 8 17 2
2010 63 47 0.15 (0.11–0.19) 39 (61.9) 6 (12.8) 4 17 2
2011 222 196 0.63 (0.58–0.68) 80 (36.0) 30 (15.3) 17 31 0
2012 55 43 0.14 (0.10–0.17) 21 (38.2) 11 (25.6) 4 18 0
2013 187 164 0.52 (0.46–0.57) 51 (27.3) 13 (7.9) 10 18 0
2014 667 658 2.07 (1.93–2.21) 63 (9.4) 53 (8.1) 23 29 0
2015 188 178 0.55 (0.50–0.61) 26 (13.8) 36 (20.2) 6 23 1
2016 86 55 0.17 (0.13–0.21) 17 (20.0) NR 4 20 0
2017 120 114 0.35 (0.30 – 0.40) 21 (17.5) NR 7 19 0
2018 375 337 1.03 (0.93–1.14) 82 (21.9) NR 17 25 0
2019 1282 1211 3.68 (3.51–3.85) 81 (6.3) 179 (14.8) 22 31 0
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US travellers. Across the Atlantic for example, the United Kingdom which initially achieved measles elimination 
in 2017, lost this status of elimination in 2018 due to a rapid rise in the number of measles cases and outbreaks 
across the  country22. Nevertheless, an overall significant reduction in the percentage of imported cases has been 
observed over the past two decades. This is in part due to the call for accelerated action in 2015 among member 
states of the World Health Organisation (WHO) Europe region to gear up against the elimination of measles and 
 rubella23. This has helped to curb the number of imported cases from Europe through improved disease surveil-
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Figure 1.  (a) Total annual incidence rate of measles and total number of measles cases between 2001 and 2019. 
(b) Annual incidence rate of measles and number of measles cases in US residents between 2001 and 2019. The 
light blue shading represents the number of cases and the connected line represents the annual incidence rate 
(AIR) per million population. The total AIR and the AIR in US residents was relatively constant between 2001 
and 2013, but there were subsequent peaks in 2014 and 2019.
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of indigenous transmission of the disease, controlling measles importation from Europe and Asia will remain a 
 challenge24. Much more therefore needs to be done with regards to the vaccination of international US travellers. 
As reported in a study by Hyle et al., high proportions of US vaccine-eligible children (44.1% of measles-mumps-
rubella (MMR) vaccination–eligible infants, 56.5% of MMR vaccine–eligible preschool-aged travellers, and 88.5% 
of MMR vaccine–eligible school-aged travellers) go unvaccinated, with the principal reasons for non-vaccination 
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Figure 2.  (a) Annual incidence rate of measles in US residents and the percentage of imported cases between 
2001 and 2019. (b) Annual incidence rate of measles in US residents and the percentage of vaccinated cases 
between 2001 and 2019. The red line represents the annual incidence rate (AIR) per million population and the 
blue connected line represents the percentage of imported cases and vaccinated respectively. Missing data on the 
percentage of vaccinated US resident cases for 2016 and 2017 in Fig. 2b. There was a decrease in the percentage 
of imported cases from 46.6% in 2001 to 6.3% in 2019.
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MMR-eligible individuals was found to be the reason for clinician refusal to administer the  vaccine25. This 
highlights the often-overlooked role of clinicians in ensuring adequate vaccine coverage. Likewise among the 
guardian refusal reasons, in up to 75% of cases, the guardians were not concerned about the illness, and less than 
10% expressed concerns about vaccine  safety25. Clinician involvement through ways of adequate education on 
current vaccination guidelines and their subsequent education of guardians through pre-travel advice in travel 
clinics and beyond, could be essential in addressing measles cases imported by non-vaccinated international US 
travellers. A stricter MMR vaccination policy depending on travel destination among international US travel-
lers could help with curbing disease importation and transmission. Likewise, compulsory measles vaccination 
policies could be extended to people working in settings with populations that have international travellers.
Table 3.  Linear regression model for annual incidence rate in US residents, percentage of imported and 
vaccinated cases and outbreaks.
Parameters Regression Coefficient Intercept P value R-square Correlation Coefficient
Annual incidence rate
Percentage of imported cases – 0.027 1.503 0.008 0.35 – 0.59
Percentage of vaccinated cases – 0.036 1.191 0.308 0.07 – 0.27
Outbreaks
Percentage of imported cases – 0.205 15.579 0.006 0.37 – 0.61
Percentage of unvaccinated cases 0.329 – 19.182 0.249 0.12 0.35
States affected










0 20 40 60 80
Percentage of imported cases






5 10 15 20 25 30
Percentage of vaccinated US resident cases







0 20 40 60 80








70 75 80 85 90 95
Percentage of unvaccinated US resident cases
Outbreaks Fitted values
Figure 3.  (a) Linear regression model of the association between the annual incidence rate and the percentage 
of imported cases. (b) Linear regression model of the association between the annual incidence rate and the 
percentage of vaccinated cases. (c) Linear regression model of the association between the number of outbreaks 
and the percentage of imported cases. (d) Linear regression model of the association between the number of 
outbreaks and the percentage of unvaccinated cases.
8
Vol:.(1234567890)
Scientific Reports |           (2021) 11:51  | https://doi.org/10.1038/s41598-020-80214-3
www.nature.com/scientificreports/
It is, however, worth noting that with the decreasing percentage of imported cases of measles in the US over 
the years, the increasing number of outbreaks across the country could suggest that internal transmission of the 
disease following importation, most probably among unvaccinated communities, could be driving the sustained 
increase in the AIR of measles in the US. Failure to vaccinate is traditionally known to be the main reason for 
indigenous transmission of the disease following importation. As reported by previous studies, measles outbreaks 
occurred largely in communities with high proportions of unvaccinated people, with restrictions on  vaccination9. 
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Figure 4.  (a) Number of measles outbreaks and number of states affected by measles between 2001 and 2019. 
The red connected line represents the number of states affected and the blue connected line represents the 
number of outbreaks. There was a significant increase in the number of outbreaks from 10 in 2001 to 22 in 2019. 
There was a significant increase in the number of states affected from 16 in 22 in 2001 to 31 in 2019. (b) Linear 
regression model of the association between the number of outbreaks and the number of states affected.
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Sustained disease transmission in a population with a high vaccination coverage should also raise the concern of 
a potential waxing conferred immunity or vaccine failure among vaccinated subjects. The study by Clemmons 
et al., is rather in favour of failure to vaccinate rather than failure of the vaccine as the main reason for persistent 
disease transmission between 2001 and  201510.
The increasing number of outbreaks and states affected by measles over the years implies continued surveil-
lance of pockets of transmissions and rapid containment of local outbreaks are essential to prevent the spread of 
the disease to other states and the subsequent re-establishment of disease transmission post-elimination. Effective 
local containment can be achieved by ensuring response teams are set-up in advance to expedite containment. 
Extra proposed measures could involve actively searching for additional cases, administering the vaccine to 
every one above 6 months of age in addition to susceptible contacts, and introducing social distancing measures 
in extreme  cases27.
Another important finding was the high percentage of vaccine-eligible individuals who declined vaccina-
tion due to religious beliefs. Currently, the measles vaccine, which is a live attenuated vaccine, is administered 
as part of the MMR or the measles-mumps-rubella-varicella (MMRV) combination together with the mumps, 
rubella and varicella vaccines respectively. The CDC recommends it is administered to all children 12 months 
of age and older, susceptible adolescents and adults without documented evidence of  immunity6. The first dose 
is often given on or after the first birthday and the second dose at least 4 weeks after, and routinely administered 
at age 4–6 years. Despite these recommendations, vaccine hesitancy has been gaining grounds within the USA 
with reported instances in states like  Texas14. Vaccine hesitancy negatively affects vaccine coverage and hence 
the herd immunity conferred unto non-immune individuals. Vaccine hesitancy is of public health concern as 
current data suggest that just a 5% drop in MMR coverage leads to a threefold increase in measles (age group 
2–11 years) cases yearly and an equivalent $2.1 million cost on the public sector, constituting a significant eco-
nomic burden to the  US28. As a highly infectious disease, still endemic in several regions in the world, measles 
transmission is expected to persist and the identification of cases among travellers entering the US will always 
constitute a challenge. Therefore, controlling indigenous transmission by taking a step further on the current 
control measures is essential in decreasing the burden of measles on the US population.
The interpretation of our findings should take into consideration the following limitations: As with all ecologi-
cal studies, there is the possibility of the ecological fallacy when inferences are made at individual level. This study 
analysed population data over the past two decades, and our findings on vaccination status and case importations 
may therefore not apply to individuals in specific communities. Despite the use of standard case definitions, 
variations in case detection and consequently annual incidence rates are highly dependent on the sensitivity of 
the surveillance systems which tends to vary over time. The findings of this study may not apply to other settings 
with similar or different measles epidemiology. Despite these limitations, this study provides potential reasons 
for the resurgence of measles in the US in recent years and possible solutions to help with its control.
Conclusions
Despite the overall reduction in the percentage of imported cases of measles in the US over the past two dec-
ades, pockets of internal transmission of the disease following importation via increasing number of outbreaks 
in unvaccinated subpopulations, reinforced by vaccine hesitancy, account for the increasing incidence rates of 
the disease in the US. Taking a step further on the current control measures to control indigenous transmission 
through efficient vaccination coverage in at-risk subpopulations and among international US travellers, improved 
disease surveillance and rapid outbreaks containment are essential in curbing the resurgence of measles in the US.
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on 
reasonable request.
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